⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13590067 | 0.75 | ACE (0.39) | — | |
| SCHEMBL12316251 | 0.73 | — | — | |
| SCHEMBL10345078 | 0.73 | — | — | |
| SCHEMBL930337 | 0.71 | — | — | |
| SCHEMBL18643386 | 0.71 | — | — | |
| SCHEMBL11785762 | 0.71 | — | — | |
| SCHEMBL1962359 | 0.71 | — | — | |
| SCHEMBL8986221 | 0.71 | — | — | |
| SCHEMBL1146799 | 0.71 | — | — | |
| SCHEMBL201888 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024112876-A2 | SPLIT SYNTHESIS OF LONG RNAS | PRIME MEDICINE, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| US-20180099005-A1 | CHITOSAN COVALENTLY LINKED WITH SMALL MOLECULE INTEGRIN ANTAGONIST FOR TARGETED DELIVERY | HOFFMANN-LA ROCHE, INC. | 2018-04-12 | — | — | US | disclosed |
| US-9593156-B2 | Insulin analog dimers | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2017-03-14 | — | — | US | disclosed |